Fibrin u tkivnom inženjerstvu kože – proizvodnja i kliničko iskustvo by Antun Kljenak et al.
Acta Clin Croat 2016; 55:279-289 Review
doi: 10.20471/acc.2016.55.02.15
Acta Clin Croat, Vol. 55, No. 2, 2016  279
FIBRIN GEL AS A SCAFFOLD FOR SKIN SUBSTITUTE 
– PRODUCTION AND CLINICAL EXPERIENCE
Antun Kljenak1, Mirna Tominac Trcin2, Marina Bujić2, Tamara Dolenec2, Martina Jevak2, 
Gordan Mršić3,4, Gordana Zmiš2, Zoran Barčot1, Ante Muljačić2 and Maja Popović4
1Zagreb Children’s Hospital; 2Tissue Bank, University Department of Traumatology, Sestre milosrdnice 
University Hospital Center; 3Ivan Vučetić Center for Forensic Investigations, Research and Expertise; 
4Department of Biology, Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia
SUMMARY – Th e purpose of this study was to create a fi brin-based human skin substitute in 
vitro with epidermal and dermal component and to assess its healing potential in deep partial and full 
thickness burns. Fibrin scaff olds were prepared from commercial fi brin glue kits. Human fi broblasts 
were cultured in fi brin gel. Human keratinocytes were seeded on the top of the gel. Viability of cells 
was determined fl uorimetrically. Scanning electron microscope and immunocytochemistry analysis of 
cultured cells were performed. After hydrosurgical preparation of deep burn necrotic tissue, wound 
bed was prepared for skin substitutes. Progress of healing was documented using visual estimation and 
photos. Scanning electron microscope images showed good cell attachment and colony spreading of 
keratinocytes and fi broblasts on fi brin scaff old. Immunofl uorescent staining of cell cultures on fi brin 
scaff old showed expression of vimentin, a marker of fi broblast cells, cytokeratin 19, a marker of epi-
thelial stem cells, as well as involucrin, a marker of diff erentiated keratinocytes. Clinical results clearly 
showed that appearance of the skin did not diff er signifi cantly from the areas of transplanted skin 
using split-thickness skin graft techniques. In conclusion, using these fi brin-cultured autografts on 
massive full-thickness burn resulted in good healing.
Key words: Cells, cultured; Fibrin; Skin, artifi cial; Burns
Correspondence to: Mirna Tominac Trcin, PhD, MS, Tissue Bank, 
University Department of Traumatology, Sestre milosrdnice Uni-
versity Hospital Center, Draškovićeva 19, HR-10000 Zagreb, 
 Croatia
E-mail: mirna.tomtrcin@gmail.com
Received April 14, 2015, accepted January 19, 2016
Introduction
Th e treatment of burns becomes much more com-
plicated when wounds are deep and extensive. When a 
burn has penetrated deeper into the dermis, skin re-
generation relies only on stem cell reservoirs located in 
epithelial appendages such as hair follicles, sebaceous 
glands, and sweat glands1-4. When these reservoirs are 
destroyed, epithelialization can only start from wound 
margins. For deep partial and full thickness burns, ne-
crotic tissue excision and wound closure with epider-
mal and partial dermal substitution is mandatory. Th e 
existence of dermal components is necessary for skin 
repair. At the end of the infl ammation phase of the 
wound healing process, the fi rst wave of fi broblasts mi-
grates from dermal margins to the wound bed attract-
ed by local growth factors/cytokines. Th ey start to pro-
liferate and form granulation tissue. Fibronectin, col-
lagen, hyaluronan, and other components of granula-
tion tissue create a moist environment which facilitates 
further cell migration. In the proliferative and remod-
eling phases of healing, the keratinocyte-fi broblast in-
terplay becomes dominant. Re-epithelialization starts 
as soon as granulation tissue fi lls an open wound; epi-
thelial cells move over the surface of this provisional 
matrix, creating a barrier between the wound and the 
environment5. Studies of keratinocyte and fi broblast 
cocultures show that keratinocytes stimulate fi bro-
blasts to synthesize growth factors, which in turn stim-
ulate keratinocyte proliferation in a double paracrine 
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manner. Both types of cells contribute to the synthe-
sis of macromolecules of basement membrane. Fi-
broblasts produce collagen type IV and VII, laminin 
5, nidogen, and transforming growth factor beta 
(TGF-b), which in turn stimulates keratinocytes to 
synthesize collagen type IV and VII. Considering the 
importance of the keratinocyte-fi broblast interaction 
for the wound healing process, creating a complete 
skin equivalent with epidermal and dermal compo-
nents has become a major focus of recent tissue engi-
neering research6, 7.
Th e choice of artifi cial extracellular matrix or scaf-
fold is particularly important. It off ers skin stem cells 
an optimal environment for in vitro growth and dif-
ferentiation. Scaff olds for skin engineering must meet 
three basic criteria: patient safety, clinical effi  cacy, and 
convenience of use8. Th ey should also have good me-
chanical and physical properties, controlled degrada-
tion rate, low immunogenicity, etc.9,10.
Fibrin as a natural, biodegradable polypeptide is 
involved in the initial phase of wound healing. Th e fi -
brin network provides a temporary scaff old which di-
rects the early migration of fi broblasts and vascular 
endothelial cells into the wound bed11. Fibrin gel is 
frequently used in medicine as a tissue fi xative. Over 
the last twenty years, it has been extensively studied in 
the tissue engineering fi eld as a cell scaff old and as a 
material for delivering growth factors and genes to 
promote wound healing. Fibrin hydrogels could be 
prepared from commercial fi brin glue or from the pa-
tient’s own plasma. Th ey are used in tissue engineering 
of bone, skin, as well as cartilage, dental, cardiac and 
eye tissue12,13. Th e utilization of fi brin gel in skin engi-
neering started in 1988, with fi brin glue fi xation of 
cultivated keratinocytes to the wound bed14. In several 
studies, burned patients were successfully treated with 
keratinocytes in fi brin gel15-17. Fibrin has also been 
used as a scaff old for cultivating dermal cell compo-
nents. Th e presence of dermal fi broblasts in fi brin gel 
stimulated keratinocyte migration, increased the se-
cretion of vascular endothelial growth factor (VEGF), 
improved regeneration of mature epidermal structure 
after in vivo transplantation, and promoted migration 
of vascular endothelial cells18-23.
Th e aim of our study was in vitro creation of a fi -
brin-based substitute with epidermal and dermal com-
ponents. We tested the viability of human keratino-
cytes and fi broblasts grown in this fi brin matrix. Th is 
substitute was consequently applied to the burn areas 
of patients with deep partial and full thickness burns.
Patients and Methods
Ethics
Human skin samples were used upon approval 
granted by the Ethics Committee of the Clinical De-
partment of Traumatology and having obtained in-
formed consents from the patients.
Cell isolation and culture
For clinical application, upon Ethics Committee 
approval, human skin samples of approximately 2 cm2 
were obtained from patient 1, a 14-year-old boy with 
electrocombustion and 65% of Total Body Surface 
Area (TBSA) burns caused by high voltage, and from 
patient 2, a 5-year-old patient with combustion, 95% 
TBSA burns caused by hot water. Burns were of depth 
degree IIb-III. Skin samples for cultivation were used 
from donor sites in non burned areas. In all other tests, 
skin cells from surgical surplus tissue were used. Cell 
isolation and culture were carried out under aseptic 
conditions in a clean room facility. Skin samples were 
washed in antibiotic-antimycotic solution (ABAM; 
Invitrogen, Carlsbad, California, USA) with ampho-
tericin B (2 g/mL), penicillin (100 U/mL) and strep-
tomycin (0.1 mg/mL) and placed overnight at 4 °C in 
a solution of 4.4 mg/mL Dispase (Invitrogen, Carls-
bad, California, USA) in phosphate buff ered saline 
(PBS; Sigma Aldrich, St. Louis, Missouri, USA). Th e 
next day, the epidermis was peeled off  from the dermis. 
Both skin parts were cut into small fragments. Dermal 
fragments were placed in Petri dish with fi broblast 
growth medium containing Dulbecco’s Modified Ea-
gle Medium (DMEM; Invitrogen, Carlsbad, Califor-
nia, USA), 10% of heat inactivated Australian Fetal 
Bovine Serum (FBS; Invitrogen Gibco, USA), ABAM 
(1%) and 1% L-glutamine (Invitrogen, Carlsbad, Cali-
fornia, USA). Fibroblasts were cultured at 37 °C, 5% 
CO
2
 until 80% confl uence. Afterwards, they were pas-
saged. Fibroblasts from the second or third passage 
were used for all other experiments. Epidermal parts 
were incubated with 0.25% trypsin (Sigma Aldrich, 
St. Louis, Missouri, USA) at 37 °C for 30 minutes. 
Trypsin was neutralizated with keratinocyte growth 
medium containing 10% FBS, 2:1 DMEM: Ham’s 
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F-12 (Invitrogen, Carlsbad, California, USA), 2% L-
glutamin, 1% ABAM, 5 μg/mL insulin (Sigma Al-
drich, St. Louis, Missouri, USA), 0.18 mM adenine 
(Sigma Aldrich, St. Louis, Missouri, USA), 0.4 μg/mL 
hydrocortisone (Sigma Aldrich, St. Louis, Missouri, 
USA), 0.1 nM cholera toxin (Accurate Chemicals & 
Sicentifi c Corporation, New York, USA), 2 nM triio-
dothyronine (Sigma Aldrich, St. Louis, Missouri, 
USA) and 10 ng/mL epidermal growth factor (EGF) 
(Sigma Aldrich, St. Louis, Missouri, USA). Isolated 
cells were seeded at a 2:1 ratio on a lethally irradiated 
feeder layer of 3T3 cells. Culture medium was changed 
every third day. Cells were passaged at 80% of confl u-
ence. Keratinocytes from the second passage were used 
in all other procedures.
Preparation of cultured epithelial autografts
Cultured epithelial autografts (CEA) were pre-
pared for clinical application according to the Rhein-
wald and Green method (Fig. 1a)24. Keratinocytes 
were cultured on a feeder layer of irradiated 3T3 cells 
at a 2:1 ratio in 75 cm2 tissue culture fl asks until full 
confl uence. On the day of grafting, epithelial sheets 
were detached with Dispase (Invitrogen, Carlsbad, 
California, USA) from tissue culture fl asks and mount-
ed on sterile silicon gauze (Mepitel, Mölnlycke Health 
Care AB, Gothenburg, Sweden). Sheets were washed 
and delivered to the operation room in serum free me-
dium.
Preparation of skin equivalent on fi brin scaff old
Fibrin scaff olds were prepared aseptically from 
commercial 2 mL fi brin glue kits (Tisseel, Baxter AG, 
Vienna, Austria, EU) containing fi brinogen, aprotinin 
and thrombin components17. All components of the 
kit were kept in water bath at 37 °C prior to manipula-
tion. Fibrinogen powder was dissolved in 1 mL apro-
tinin and equal volume of solubilization saline con-
taining 1.1% NaCl and 1 mM CaCl
2
. Th rombin part 
was reconstituted with the same saline from 500 IU/
mL to 3 IU/mL and mixed, for clinical purpose, with 
human dermal fi broblasts, 20 000 cells/cm2 (Fig. 1b). 
Equal parts of thrombin and fi brinogen solution were 
added simultaneously with duploject application sys-
tem into tissue culture vessels: (Ø=90 mm) Petri dish-
es or 75 cm2 fl asks. In order to prevent strong gluing of 
the fi brin scaff old to the surface of the vessel, caused by 
negative charge of cell culture plastic for adherent cells, 
nonadherent variant of tissue plastic was used. Fibro-
blast growth medium was added after fi brin gel po-
lymerization. Fibroblast cultures were kept in incuba-
tor at 37 °C, 5% CO
2
. When fi broblasts in fi brin gel 
reached 80% of confl uence, keratinocytes without 
feeder layer were seeded on the top of the gels at a 
concentration of 40 000 cells/cm2. Keratinocyte growth 
medium was supplemented with tranexamic acid 
(Cyklokapron, Pfizer, Karlsruhe, Germany) to prevent 
fibrinolysis of gel by growing cells. Medium was 
changed every third day. For clinical application, gels 
at 70%-90% of keratinocyte confl uence were delivered 
to the operation room in sterile Petri dishes with se-
rum free medium without tranexamic acid (Fig. 1b). 
For viability tests, scanning electron microscope 
Fig. 1. Cultured epithelial autografts (Rheinwal and 
Green method) (A) and skin equivalent on fi brin scaff old 
(B) ready for clinical application.
1A)
1B)
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(SEM) and immunocytochemistry analysis, fi broblasts 
and keratinocytes were cultured individually, as de-
scribed below, on fi brin scaff old.
Viability of cells cultured on fi brin scaff old
Normal human fi broblasts from 9 donors were 
seeded at a concentration of 100 000 cells/well on fi -
brin gels (as described previously) and in 96-well tis-
sue culture plastic plates for adherent cultures. Cells 
were cultured for 4 days in fi broblast growth medium. 
Normal human keratinocytes from 9 donors were 
seeded at a concentration of 15 000 cells/well with ir-
radiated 3T3 feeder layer (1:1 ratio in 96 well-plate on 
fi brin gel and on tissue culture plastic for adherent cul-
tures). Cells were cultured for 10 days in keratinocyte 
growth medium. Twenty μL of CellTiter-Blue (Pro-
mega, Madison, WI, USA) reagent was added to 100 
μL cell culture medium in each well according to the 
manufacturer’s instructions. After 4-h incubation at 
37 °C and 5% CO
2
, metabolically active cells reduced 
indicator dye resazurin into resorufi n, a highly fl uores-
cent product. Nonviable cells rapidly lost their meta-
bolic capacity, did not reduce the indicator dye, and 
fl uorescent signal was not detected. Th e measured fl u-
orescence was proportional to the number of viable 
cells. All tests were performed in triplicate. Fluores-
cent signal was measured by fl uorometer (Fluoroskan 
II, Labsystems, USA) using a set of fi lters 
(544Ex/590Em).
Immunofl uorescence
Human keratinocytes with irradiated feeder layer 
of 3T3 cells (at a 1:1 ratio) and human fi broblasts were 
seeded at a concentration of 100 000 cells/well on fi -
brin gels in tissue culture grade glass chamber slides 
(Becton Dickinson Co., New Jersey, USA). Fibroblast 
or keratinocyte growth medium was changed every 
third day. Indirect immunocytochemistry was per-
formed at 70% of cell culture confl uence. All antibod-
ies were diluted in 1% bovine serum albumin (BSA) 
solution in PBS (Sigma Aldrich, St. Louis, Missouri, 
USA). Cells were fi xed for 10 minutes in 4% parafor-
maldehyde and permeabilized in 0.1% Triton X-100 
(Sigma Aldrich, St. Louis, Missouri, USA) for 5 min-
utes. Samples were incubated with primary antibodies 
for 1 hour at room temperature. For fi broblast staining, 
primary goat antibody (whole serum) against human 
vimentin (Sigma Aldrich, St. Louis, Missouri, USA) 
was used at 1:20 dilution. For keratinocyte staining, 
monoclonal mouse antibody against human cytokera-
tine (CK) 19 (clone RCK108, Dako Denmark A/S, 
Agilent technologies, Santa Clara, USA) was diluted 
at 1:100. Mouse immunoglobulin (Ig) IgG1 antibody 
against human involucrin (clone SY5, Sigma Aldrich, 
St. Louis, Missouri, USA) was prepared at 1:50 dilu-
tion. Immunoreactivity of primary antibodies was vi-
sualized with secondary antibodies: rabbit anti-goat 
IgG fl uorescein isothiocyanate (FITC) antibody (Sig-
ma Aldrich, St. Louis, Missouri, USA) at 1:400 dilu-
tion or rabbit anti-mouse IgG Alexa Flour 488 (Invit-
rogen, Carlsbad, California, USA) at 1:1000 dilution. 
Antibodies were incubated for 30 minutes in dark 
place at room temperature and counterstained with 
Propidium Iodide (Sigma Aldrich, St. Louis, Mis-
souri, USA) 20 μg/mL for 5 minutes. Finally, the cells 
were treated with an antifade reagent (Prolong Anti-
fade kit, Invitrogen, Carlsbad, California, USA) and 
observed under confocal microscope (TCS SP2 
AOBS, Leica, Wetzlar, Germany).
Scanning electron microscope observation 
of cell cultures
Human fi broblasts or keratinocytes were seeded on 
the top of fi brin gels in 24-well culture plate, as de-
scribed previously. Cells were grown until 80% of con-
fl uence and analyzed with SEM (ESEM Philips 
XL30, Amsterdam, Netherlands).
Clinical application
Appropriate covering of burned parts of the body is 
vital for favorable results. Good preparation of wound 
bed is mandatory. In this study, the hydrosurgical 
VERSAJET system was used. Th is approach enables 
the surgeon to precisely select, excise and evacuate 
nonviable tissue, bacteria and contaminants from 
burned wound using a tissue-preserving technique. 
After hydrosurgical preparation of deep burn necrotic 
tissue, wound bed was prepared for Split-Th ickness 
Skin Grafts (STSG), CEA or skin equivalents (Fig. 2). 
STSG, as valuable transplants of limited quantity in 
extensive burns, were put on the degree III wound ar-
eas with irregular surfaces. CEA were put on the de-
gree IIb-III wound areas with even surfaces and dis-
tant margins (the patients’ back and legs) and then 
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fi xed to the surface with surgical staples. Skin equiva-
lents were put on the areas that did not heal after the 
CEA application (the shoulder and the thigh).
Bacteriological status of the graft bed was moni-
tored at regular intervals. Th e grafted areas were then 
covered with surgical non-adherent dressing. Signs of 
possible bleeding or infection were monitored daily. 
Dressings were changed twice a week. Progress of the 
healing was documented using visual estimation (vi-
sual estimation of scar height, pliability, surface area, 
texture, pigmentation, and vascularity) and photos.
Statistical analysis
Statistical analysis for viability studies was per-
formed using the Statistica 9 (StatSoft Inc., 2010) 
software. Intensity of resorufi n fl uorescence was used 
as a value proportional to the number of viable cells. 
One-way ANOVA and Tukey post-hoc tests were 
used. Statistical signifi cance was set at P<0.05.
Results
Cultures were regularly examined using inverted 
phase-contrast microscope (MBL 3100, A. Krüss Op-
tronic, Germany). In epithelial cultures on feeder layer, 
keratinocytes had a characteristic polygonal morphol-
ogy. At lower stage of confl uence (Fig. 3a), the sup-
porting feeder layer of sub lethally irradiated mouse 
3T3 cells and melanocytes with their dendritic mor-
phology were still visible. Feeder cells, unable to divide, 
were metabolically active long enough to support 
growth and proliferation of keratinocytes. As kerati-
Fig. 2. Grafting of prepared wound bed with cultured epithelial autografts in patient 1 (A) and patient 2 (B), 
and with skin equivalents on fi brin scaff old in patient 1 (C, D).
2A) 2B)
2D)2C)
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nocyte colonies spread across the surface of tissue cul-
ture vessel, 3T3 cells died. Dead feeder cells were re-
moved from the fl ask during regular medium change. 
Fully confl uent keratinocyte cultures formed multilay-
ered epithelial sheet ready for harvesting (Fig. 3b). 
Cultures of dermal fi broblasts showed bipolar spindle 
morphology (Fig. 4a). Cells cultured on fi brin gel were 
less visible when compared to those cultured on plas-
tics (Fig. 3c and 4b). SEM images showed good cell 
attachment and colony spreading of keratinocytes and 
fi broblasts on fi brin scaff old (Fig. 5).
In CellTiter-Blue test, only metabolically active, vi-
able cells reduced the indicator dye, resazurin into fl uo-
rescent resorufi n. Th is product gave measurable fl uores-
cent signal that was proportional to the number of viable 
Fig. 3. Human keratinocytes cultured on plastic 
or fi brin scaff old. Morphology was observed with inverted 
phase-contrast microscope. Feeder cells were visible 
at low confl uency (A); confl uent culture formed 
multilayered epithelial sheet (B); and fully confl uent 




Fig. 4. Human fi broblasts observed with inverted phase-
contrast microscope. Cultures at 80% of confl uency 
on tissue culture plastic (A) and fi brin (B) scaff old.
4A)
4B)
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cells. Human keratinocytes and fi broblasts proliferated 
well on both surfaces (Fig. 6). Statistical analysis using 
One-way ANOVA and Tukey post-hoc tests showed 
no significant diff erence in terms of cell viability be-
tween tissue culture plastic and fibrin scaff old (P>0.05).
Immunofl uorescent staining of keratinocyte cul-
tures on fi brin scaff old showed expression of CK19 
(marker of epithelial stem cells) and involucrin (mark-
er of diff erentiated keratinocytes) (Fig. 7). Fibroblast 
cultures were identifi ed based on vimentin expression 
(Fig. 8)25. Clinical results clearly showed that appear-
ance of the skin did not diff er signifi cantly from the 
areas of transplantated skin using STSG techniques or 
CEA. Th e epidermis was undistinguishable from nor-
mal epidermis.
Discussion
For more than 30 years, CEA have been used in the 
treatment of heavily burned patients24,26,27. Although a 
great step ahead in regenerative medicine was made, 
clinical results were not consistent and their applica-
tion was associated with numerous problems. Reports 
on CEA take greatly vary from 15% to 85%. Better 
results were achieved in those burns with proper 
wound bed preparation, which could be further en-
hanced by the presence of some kinds of dermal ele-
ments27. One of the major problems associated with 
the production of CEA is long cultivation time to get 
confl uent, ‘ripe’ multilayered epithelial sheets that can 
be detached from tissue culture vessels. Meanwhile, 
Fig. 5. Scanning electron microscope images of human keratinocytes (A) and fi broblasts (B) grown on fi brin scaff old.
5A) 5B)
Fig. 6. CellTiter-Blue® Assay of human keratinocytes (A) and fi broblasts (B) of nine donors, cultured on fi brin scaff old 
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wounds must be covered with temporary substitutes. 
Th e enzyme dispase was used for detachment of a 
CEA sheet. Unfortunately, dispase treatment may also 
impair keratinocyte attachment to the wound bed due 
to the loss of intergin 6ß4 expression and changes in 
basement protein expression28,29. In confl uent sheets, 
more keratinocytes are induced to exit highly prolif-
erative state and enter the irreversible process of termi-
nal diff erentiation. In terminal diff erentiation, their 
colony forming effi  ciency is considerably lower30. 
Some of these problems could be minimized by using 
cultured skin substitutes that contain both epidermal 
and dermal components cultured on proper scaff old. 
Bearing this in mind, cultured skin substitutes on fi -
brin scaff old were cultivated. Cells were cultured until 
80% of confl uence and then transplanted to the pa-
tient. Th e use of subconfl uent cells enables more fl exi-
ble planning of clinical application, and better adapta-
tion to patient’s needs. Th ese substitutes are easy to 
manipulate, fl exible, transparent and adhere well to the 
wound bed.
Inverted phase contrast and SEM images of fi bro-
blasts and keratinocyte cultures on fi brin gel showed 
typical cell morphology and even cell distribution 
along the scaff old surface. Immunofl uorescence analy-
sis pointed out that keratinocyte cultures on fi brin 
contained mixed population of cells with the portion 
of stem cell like cells positive to CK19. CK19, a fi -
brous protein localized on epidermis and hair follicles, 
and may be used as a marker for skin and hair follicle 
Fig. 7. Immunofl uorescent staining of human keratinocytes cultured on fi brin scaff old. Cells were positive 
for cytokeratin 19 (A) and involucrin (B).
Fig. 8. Immunofl uorescent staining of human 
fi broblasts cultured on fi brin scaff old. Cells were positive 
for vimentin.
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stem cell involved in the regeneration and restoration 
of skin and growth. Th is indicated a high proliferative 
capacity of cell cultures30. Presence of diff erentiated 
keratinocytes was detected with involucrin2. Th e  results 
of this study were in corcordance with the study of 
Pellegrini et al. 17.
When primary cultures of normal cells are cloned, 
three types of colony grow, called holoclones, mero-
clones and paraclones. Holoclones are derived from 
stem cells capable of extensive proliferation and self-
renewal. Early stage transit-amplifying cells form 
meroclones with limited proliferative capacity and no 
ability of self-renewal. Paraclones consist of late stage 
transit-amplifying cells, incapable of further prolifera-
tion24. Pellegrini et al.. used the same method of fi brin 
scaff old preparation as in this study. Th ey showed nor-
mal relative percentages of keratinocyte holoclones, 
meroclones and paraclones during cultivation on fi brin 
gel. Moreover, they also proved that keratinocytes pre-
served their clonogenic ability, growth rate and long-
term proliferation potential of the graft17..
We have to emphasize that we detected cultured 
fi broblasts in fi brin gel based on vimentin expression7. 
Keratinocyte and fi broblast viability on plastic and fi -
brin scaff old was very similar, without statistically sig-
nifi cant diff erences. In clinical application, our results 
using skin equivalents did not show more frequent lo-
cal incidence of scar formation as compared to ‘classic’ 
techniques of STSG skin grafting (Figs. 9 and 10). 
Th ese data are highly consistent with other studies16-21.
Unlike classic CEA, skin substitutes with fi brin gel 
are easier to apply in periarticular body portions, i.e. on 
uneven body surfaces surrounding movable joints, ow-
ing to the fact that the fi brin component of the skin 
substitute glues the graft and no additional staples are 
necessary.
In conclusion, using fi brin-cultured skin substi-
tutes on massive full-thickness burn will result in good 
healing (Fig. 10) over up to 3-year follow up.
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Sažetak
FIBRIN U TKIVNOM INŽENJERSTVU KOŽE 
– PROIZVODNJA I KLINIČKO ISKUSTVO
A. Kljenak, M. Tominac Trcin, M. Bujić, T. Dolenec, M. Jevak, G. Mršić, 
G. Zmiš, Z. Barčot, A. Muljačić i M. Popović
Cilj ovoga istraživanja bio je kreirati in vitro nadomjestak ljudske kože s epidermalnim i dermalnim dijelom. Pritom smo 
koristili fi brinski gel kao nosač stanica. Procijenili smo učinak nadomjestka kože na cijeljenje opeklina drugog i trećeg 
 stupnja. Fibrinski gel načinjen je od komercijalnog kirurškog fi brinskog ljepila. Ljudski fi broblasti kultivirani su u samom 
fi brinskom nosaču. Ljudski keratinociti zasijani su na gornju površinu nosača. Vijabilnost uzgojenih stanica određena je 
fl uorimetrijski. Nadomjestak kože analiziran je elektronskim skenirajućim mikroskopom. Napravljena je imunocitokemijska 
analiza kultiviranih stanica. Skenirajući mikroskop pokazao je dobro prianjanje i proliferaciju stanica kože na nosaču. Imu-
nocitokemijska analiza pokazala je prisutnost vimentina, biljega fi broblastnih stanica; citokeratina 19, biljega epitelnih 
 matičnih stanica; te involukrina, biljega diferenciranih keratinocita. Klinička primjena ovih nadomjestaka kože pokazala je 
slične rezulatate cijeljenja kao i dijelovi rana koji su prekriveni autolognim presatcima kože djelomične debljine. Zaključu-
jemo da nadomjestci kože bazirani na fi brinskom nosaču imaju potencijala u liječenju teških opeklina.
Ključne riječi: Stanice, kultivirane; Fibrin; Koža, umjetna; Opekline
